Search Within

Boglarka Gyurkocza

Formats
  1. Meeting Abstract (91)
  2. Journal Article (39)
  3. Research Letter (7)
  4. Review (1)
Groups
  1. Bone Marrow Transplant (138)
  2. Center for Hematologic Malignancies (138)
  3. Department of Medicine (138)
  4. Hematologic Malignancies, Division of (138)
  5. Survivorship Research (138)
  6. CTCR Scholars (104)

More Groups

People
  1. Sergio Giralt (117)
  2. Miguel-Angel Perales (97)
  3. Roni Tamari (80)
  4. Brian Shaffer (79)
  5. Esperanza Papadopoulos (77)
  6. Sean Devlin (72)

More People

Years
  1. 2025 (3)
  2. 2024 (7)
  3. 2023 (20)
  4. 2022 (14)
  5. 2021 (10)
  6. 2020 (21)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (40)
  2. Blood (40)
  3. Bone Marrow Transplantation (13)
  4. Blood Advances (9)
  5. Transplantation and Cellular Therapy (9)
  6. Clinical Lymphoma, Myeloma and Leukemia (4)

More Publications

Publishers
  1. Elsevier Inc. (53)
  2. American Society of Hematology (49)
  3. Nature Publishing Group (13)
  4. American Society of Clinical Oncology (4)
  5. John Wiley & Sons, Inc. (3)
  6. American Association for the Advancement of Science (2)

More Publishers

Results (138)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • High progression-free survival after intermediate intensity double unit cord blood transplantation in adults
    Journal Article

    Barker, J. N.; Devlin, S. M.; Naputo, K. A.; Skinner, K.; Maloy, M. A.; Flynn, L.; Anagnostou, T.; Avecilla, S. T.; Scaradavou, A.; Cho, C.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Targeted conditioning with anti-CD45 iodine ((131)I) apamistamab [Iomab-B] leads to high rates of transplantation and engraftment in older patients with active, relapsed, or refractory (rel/ref) AML: Preliminary midpoint results from the prospective, randomized phase 3 SIERRA trial
    Meeting Abstract

    Gyurkocza, B.; Nath, R.; Stiff, P.; Agura, E.; Litzow, M.; Tomlinson, B.; Choe, H.; Abhyankar, S.; Seropian, S.; Chen, G.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2020)

    Fulltext@MSK | Save
  • Favorable long-term outcomes of hematopoietic stem cell transplantation for CMML with myeloablative conditioning, anti-thymocyte globulin, and CD34(+) selected graft
    Research Letter

    Lin, R. J.; Sanchez, M.; Abbi, K.; Devlin, S. M.; Jakubowski, A. A.; Papadopoulos, E. B.; Barker, J. N.; Tamari, R.; Young, J. W.; Gyurkocza, B.; more...
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • A single-center, open-label trial of isavuconazole prophylaxis against invasive fungal infection in patients undergoing allogeneic hematopoietic cell transplantation
    Journal Article

    Stern, A.; Su, Y.; Lee, Y. J.; Seo, S.; Shaffer, B.; Tamari, R.; Gyurkocza, B.; Barker, J.; Bogler, Y.; Giralt, S.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Feasibility of administering anti-CD45 iodine ((131)I) apamistamab [Iomab-B] for targeted conditioning in older patients with active, relapsed or refractory AML without lead-lined rooms: Ongoing phase III SIERRA trial experience at 6 study sites
    Meeting Abstract

    Nath, R.; Chu, B.; Chen, L.; Sadeghi, A.; Senglaub, T.; Kaiser, L.; Saganich, C.; Zgaljardic, M.; Rutar, F.; Harling, S.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • The impact of individual co-morbidities in myeloablative ex vivo CD34+ selected allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Shouval, R.; Fein, J. A.; Devlin, S. M.; Maloy, M. A.; Castillo Flores, N.; Lin, R. J.; Politikos, I.; Sanchez, M.; Scordo, M.; Shah, G. L.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Don't let the HCT-CI fool you: Similar outcomes with myeloablative CD34+ selected allo-HCT compared to unmodified RIC allo-HCT in patients with AML or MDS and high comorbidity scores
    Meeting Abstract

    Pennisi, M.; Cho, C.; Devlin, S. M.; Ruiz, J. D.; Maloy, M. A.; Tomas, A. A.; Castillo, N.; Lin, R. J.; Politikos, I.; Sanchez-Escamilla, M.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Transplant characteristics and outcomes of Philadelphia (Ph)-like acute lymphoblastic leukemia (ALL)
    Meeting Abstract

    Anagnostou, T.; Maloy, M. A.; Patnaik, M. M.; Arcila, M. E.; Gomez Arteaga, A.; Cho, C.; Dahi, P. B.; Gyurkocza, B.; Perales, M.; Ponce, D. M.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Prospective identification of unrelated donors with low inhibitory donor KIR3DL1- Recipient HLA-B interaction decreases relapse and improves survival after allogeneic hematopoietic cell transplantation for myeloid neoplasia
    Meeting Abstract

    Shaffer, B. C.; Park, S.; Le Luduec, J. B.; Devlin, S. M.; Jakubowski, A. A.; Gyurkocza, B.; Papadopoulos, E. B.; Tamari, R.; Giralt, S. A.; Hsu, K. C.
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Long-term survival in patients with AML or MDS relapsed after allogeneic hematopoietic cell transplantation: Importance of second cell therapy
    Meeting Abstract

    Zuanelli Brambilla, C.; Ruiz, J. D.; Lobaugh, S. M.; Dahi, P. B.; Young, J. W.; Gyurkocza, B.; Shaffer, B. C.; Ponce, D. M.; Tamari, R.; Sanchez Escamilla, M.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save